At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Arm 1: Juvenile Myoclonic Epilepsy +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Neocortical Epilepsies - Do They Progress?
In Brief
A clinical study evaluating Arm 1: Juvenile Myoclonic Epilepsy, Arm 2: Frontal Lobe Epilepsy, and 1 other intervention for Epilepsy. Completed, enrolled 60 participants across 1 site.
Detailed Summary
This study will use MRI and PET scan to compare the brain imaging results between epilepsy patients and normal healthy controls, also to study changes in 3 years.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpilepsy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2003
First PostedFeb 2008
Primary CompletionJun 2009
Study CompletionSep 2010
TodayJul 2026
First PostedFeb 8, 2008
Enrollment StartJul 1, 2003
Primary CompletionJun 1, 2009
Study CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 18.4 years ago
Interventions
Arm 1: Juvenile Myoclonic Epilepsydevice
Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI
Arm 2: Frontal Lobe Epilepsydevice
Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI
Arm 3: Normal Controlsdevice
Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI